Literature DB >> 4686826

Clinical dose response curves of human malignant epithelial tumours.

G H Fletcher.   

Abstract

Entities:  

Mesh：

Year:  1973        PMID： 4686826

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  8 in total

1.  High-dose 3-dimensional conformal radiotherapy with concomitant vinorelbine plus carboplatin in patients with non-small cell lung cancer: A feasibility study.

Authors:  Qiang Lin; Jun Wang; Yue'e Liu; Huiling Su; Na Wang; Yuehua Huang; Chao-Xing Liu; Ping Zhang; Yannan Zhao; Kun Chen
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

2.  Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancer.

Authors:  Yuhchyau Chen; Kishan J Pandya; Richard Feins; David W Johnstone; Thomas Watson; Therese Smudzin; Peter C Keng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

3.  CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy.

Authors:  Tao Zhang; Mingjian Lu; Sheng Peng; Weidong Zhang; Guang Yang; Zhenyin Liu; Sristi Singh; Yadi Yang; Fujun Zhang; Fei Gao
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-11       Impact factor: 4.553

4.  Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial.

Authors:  Qiang Lin; Yue-E Liu; Xiao-Cang Ren; Na Wang; Xue-Ji Chen; Dong-Ying Wang; Jie Zong; Yu Peng; Zhi-Jun Guo; Jing Hu
Journal:  Radiat Oncol       Date:  2013-08-17       Impact factor: 3.481

5.  Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.

Authors:  Lei Wang; Zheng Wu; Dehuan Xie; Ruifang Zeng; Wanqin Cheng; Jiang Hu; Shaomin Huang; Shu Zhou; Rui Zhong; Yong Su
Journal:  Cancer Res Treat       Date:  2018-08-13       Impact factor: 4.679

6.  A modified Phase I trial of radiation dose escalation in 3D conformal radiation therapy with concurrent vinorelbine and carboplatin chemotherapy for non-small-cell lung cancer.

Authors:  Qiang Lin; Yue'e Liu; Na Wang; Yuehua Huang; Xiaohui Ge; Xiaocang Ren; Xueji Chen; Jing Hu; Zhijun Guo; Yannan Zhao; Junichi Asaumi
Journal:  J Radiat Res       Date:  2012-09-17       Impact factor: 2.724

7.  High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.

Authors:  Yue-E Liu; Qiang Lin; Fan-Jie Meng; Xue-Ji Chen; Xiao-Cang Ren; Bin Cao; Na Wang; Jie Zong; Yu Peng; Ya-Jun Ku; Yan Chen
Journal:  Radiat Oncol       Date:  2013-08-11       Impact factor: 3.481

8.  High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis.

Authors:  Xin Sun; Lei Wang; Yang Wang; Jingjing Kang; Wei Jiang; Yu Men; Zhouguang Hui
Journal:  Front Oncol       Date:  2020-08-04       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.